Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients.

Koksal D, Demirag F, Bayiz H, Ozmen O, Tatci E, Berktas B, Aydoğdu K, Yekeler E.

J Cardiothorac Surg. 2013 Apr 4;8:63. doi: 10.1186/1749-8090-8-63.

PMID:
23557204
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.

Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.

Eur J Cardiothorac Surg. 2013 Jul;44(1):83-7. doi: 10.1093/ejcts/ezs604. Epub 2012 Dec 11.

PMID:
23233074
[PubMed - indexed for MEDLINE]
3.

Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.

Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.

Anticancer Res. 2014 Feb;34(2):805-10.

PMID:
24511016
[PubMed - indexed for MEDLINE]
4.

Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.

Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.

Clin Lung Cancer. 2013 Sep;14(5):568-73. doi: 10.1016/j.cllc.2013.02.002. Epub 2013 Jul 5.

PMID:
23835164
[PubMed - indexed for MEDLINE]
5.

Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.

Takenaka T, Yano T, Morodomi Y, Ito K, Miura N, Kawano D, Shoji F, Baba S, Abe K, Honda H, Maehara Y.

Surg Today. 2012 Oct;42(10):934-9. doi: 10.1007/s00595-012-0277-7. Epub 2012 Aug 3.

PMID:
22864936
[PubMed - indexed for MEDLINE]
6.

Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.

Billè A, Okiror L, Skanjeti A, Errico L, Arena V, Penna D, Ardissone F, Pelosi E.

Eur J Cardiothorac Surg. 2013 Mar;43(3):574-9. doi: 10.1093/ejcts/ezs366. Epub 2012 Jun 11.

PMID:
22689182
[PubMed - indexed for MEDLINE]
7.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
[PubMed - indexed for MEDLINE]
8.

Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer.

Lin WY, Hsu WH, Lin KH, Wang SJ.

J Chin Med Assoc. 2012 May;75(5):203-8. doi: 10.1016/j.jcma.2012.04.004. Epub 2012 May 12.

PMID:
22632985
[PubMed - indexed for MEDLINE]
9.

Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.

Perigaud C, Bridji B, Roussel JC, Sagan C, Mugniot A, Duveau D, Baron O, Despins P.

Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6. doi: 10.1016/j.ejcts.2009.05.044. Epub 2009 Jul 25.

PMID:
19632852
[PubMed - indexed for MEDLINE]
10.

Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.

Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T, Morikawa T, Kinoshita I, Dosaka-Akita H, Nishimura M.

Respiration. 2003 Sep-Oct;70(5):500-6.

PMID:
14665776
[PubMed - indexed for MEDLINE]
Free Article
11.

Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT.

Lee AY, Choi SJ, Jung KP, Park JS, Lee SM, Bae SK.

Nucl Med Mol Imaging. 2014 Mar;48(1):41-6. doi: 10.1007/s13139-013-0244-2. Epub 2013 Nov 6.

PMID:
24900137
[PubMed]
12.

Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET.

Nambu A, Kato S, Sato Y, Okuwaki H, Nishikawa K, Saito A, Matsumoto K, Ichikawa T, Araki T.

Ann Nucl Med. 2009 May;23(3):269-75. doi: 10.1007/s12149-009-0237-5. Epub 2009 Apr 2.

PMID:
19340527
[PubMed - indexed for MEDLINE]
13.

Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.

Lee SM, Park CM, Paeng JC, Im HJ, Goo JM, Lee HJ, Kang CH, Kim YW, Kim JI.

Eur Radiol. 2012 Jul;22(7):1556-63. doi: 10.1007/s00330-012-2395-4. Epub 2012 Feb 24.

PMID:
22358427
[PubMed - indexed for MEDLINE]
14.

Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1365-71. doi: 10.1016/j.jtcvs.2012.07.012. Epub 2012 Aug 9.

PMID:
22883546
[PubMed - indexed for MEDLINE]
15.

Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.

Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.

Ann Nucl Med. 2009 Aug;23(6):523-31. doi: 10.1007/s12149-009-0268-y. Epub 2009 May 15.

PMID:
19444550
[PubMed - indexed for MEDLINE]
16.

Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer.

Carrillo SA, Daniel VC, Hall N, Hitchcock CL, Ross P Jr, Kassis ES.

Ann Thorac Surg. 2012 May;93(5):1621-4. doi: 10.1016/j.athoracsur.2012.01.006. Epub 2012 Mar 17.

PMID:
22429676
[PubMed - indexed for MEDLINE]
17.

Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.

Li M, Wu N, Zheng R, Liang Y, Liu Y, Zhang W, Li N, Zhao P.

Cancer Imaging. 2013 Feb 7;12:566-72. doi: 10.1102/1470-7330.2012.0040.

PMID:
23399986
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?

Tandberg DJ, Gee NG, Chino JP, D'Amico TA, Ready NE, Coleman RE, Kelsey CR.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):796-801. doi: 10.1016/j.jtcvs.2013.05.027. Epub 2013 Jul 16.

PMID:
23870158
[PubMed - indexed for MEDLINE]
19.

The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.

Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.

Clin Nucl Med. 2007 Aug;32(8):607-12.

PMID:
17667432
[PubMed - indexed for MEDLINE]
20.

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA, Demedts MG.

J Clin Oncol. 1998 Jun;16(6):2142-9.

PMID:
9626214
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk